Regulatory compliance - December 8, 2014
Meda, Cipla Suing Apotex
Meda Pharmaceuticals Inc. and Cipla Ltd. announced recently that they sued Apotex Inc. and Apotex Corp. in U.S. Federal District Court in Delaware to enforce the Orange-Book listed patents covering Dymista (azelastine HCl/fluticasone propionate) Nasal Spray in response to Apotex’s submission to the U.S. Food and Drug Administration (FDA) of an Abbreviated New Drug Application (ANDA), and […]